Page last updated: 2024-08-22

tranylcypromine and Leukemia, Promyelocytic, Acute

tranylcypromine has been researched along with Leukemia, Promyelocytic, Acute in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's3 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Botrugno, OA; Brambillasca, S; Cappa, A; Cera, MR; Dessanti, P; Mercurio, C; Meroni, G; Minucci, S; Thaler, F; Trifirò, P; Varasi, M; Vianello, P; Villa, M; Zuffo, RD1
Botrugno, OA; Ciossani, G; Cirilli, R; Dessanti, P; Labella, D; Mai, A; Marrocco, B; Mattevi, A; Mercurio, C; Minucci, S; Monaldi, D; Rodriguez, V; Ruoppolo, G; Saponara, B; Tilset, M; Valente, S; Varasi, M; Vianello, P1
Botrugno, OA; Cappa, A; Dal Zuffo, R; Dessanti, P; Mai, A; Marrocco, B; Mattevi, A; Mercurio, C; Meroni, G; Minucci, S; Stazi, G; Thaler, F; Trifiró, P; Valente, S; Varasi, M; Vianello, P; Villa, M1

Other Studies

3 other study(ies) available for tranylcypromine and Leukemia, Promyelocytic, Acute

ArticleYear
Novel potent inhibitors of the histone demethylase KDM1A (LSD1), orally active in a murine promyelocitic leukemia model.
    Future medicinal chemistry, 2017, Volume: 9, Issue:11

    Topics: Animals; Antineoplastic Agents; Cell Line, Tumor; Cell Survival; Histone Demethylases; Humans; Leukemia, Promyelocytic, Acute; Mice; Structure-Activity Relationship; Tranylcypromine

2017
Pure enantiomers of benzoylamino-tranylcypromine: LSD1 inhibition, gene modulation in human leukemia cells and effects on clonogenic potential of murine promyelocytic blasts.
    European journal of medicinal chemistry, 2015, Apr-13, Volume: 94

    Topics: Animals; Antineoplastic Agents; Drug Screening Assays, Antitumor; Enzyme Inhibitors; Gene Expression Regulation, Leukemic; Histone Demethylases; Humans; Leukemia; Leukemia, Promyelocytic, Acute; Mice; Mice, Inbred Strains; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Stereoisomerism; Structure-Activity Relationship; Tranylcypromine

2015
Discovery of a Novel Inhibitor of Histone Lysine-Specific Demethylase 1A (KDM1A/LSD1) as Orally Active Antitumor Agent.
    Journal of medicinal chemistry, 2016, Feb-25, Volume: 59, Issue:4

    Topics: Administration, Oral; Antineoplastic Agents; Cell Line, Tumor; Enzyme Inhibitors; Histone Demethylases; Humans; Leukemia, Promyelocytic, Acute; Structure-Activity Relationship; Tranylcypromine

2016